Actionable insights straight to your inbox

logo_equities.svg

Moderna Raises COVID-19 Vaccine Production Forecast to At Least 600 Million Doses

The company is investing and hiring in order to try to reach 1 billion doses

Image source: Moderna

(Reuters) – Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.

The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.

Moderna said it has so far supplied about 18 million doses to U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.

Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur.

_____

Source: Reuters

To say the current situation isn’t pretty now seems an understatement, and it’s likely to remain chaotic for a while. Which is why it’s so important for leaders of all kinds not to fall prey to the very human tendency to go negative, playing the blame game.
Bargain-hunting friends of mine have been asking: “Should I buy First Republic?” After all, First Republic is prestigious. Facebook founder Mark Zuckerberg got a mortgage there. Dozens of customer surveys rate its satisfaction scores higher than super-brands like Apple and Ritz-Carlton.
Many of us economy-watchers have been expecting recession, though with significant differences on odds and timing. Regardless, recent banking developments just made recession more likely and may have accelerated its onset.